{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:28:27Z","timestamp":1787509707836,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Center for Individualized Medicine, Mayo Clinic,United States"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with rheumatoid arthritis (RA) can test either positive or negative for circulating anti-citrullinated protein antibodies (ACPA) and are thereby categorized as ACPA-positive (ACPA+) or ACPA-negative (ACPA\u2212), respectively. In this study, we aimed to elucidate a broader range of serological autoantibodies that could further explain immunological differences between patients with ACPA+\u2009RA and ACPA\u2212\u2009RA. On serum collected from adult patients with ACPA+\u2009RA (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200932), ACPA\u2212\u2009RA (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930), and matched healthy controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930), we used a highly multiplex autoantibody profiling assay to screen for over 1600 IgG autoantibodies that target full-length, correctly folded, native human proteins. We identified differences in serum autoantibodies between patients with ACPA+\u2009RA and ACPA\u2212\u2009RA compared with healthy controls. Specifically, we found 22 and 19 autoantibodies with significantly higher abundances in ACPA+\u2009RA patients and ACPA\u2212\u2009RA patients, respectively. Among these two sets of autoantibodies, only one autoantibody (anti-GTF2A2) was common in both comparisons; this provides further evidence of immunological differences between these two RA subgroups despite sharing similar symptoms. On the other hand, we identified 30 and 25 autoantibodies with lower abundances in ACPA+\u2009RA and ACPA\u2212\u2009RA, respectively, of which 8 autoantibodies were common in both comparisons; we report for the first time that the depletion of certain autoantibodies may be linked to this autoimmune disease. Functional enrichment analysis of the protein antigens targeted by these autoantibodies showed an over-representation of a range of essential biological processes, including programmed cell death, metabolism, and signal transduction. Lastly, we found that autoantibodies correlate with Clinical Disease Activity Index, but associate differently depending on patients\u2019 ACPA status. In all, we present candidate autoantibody biomarker signatures associated with ACPA status and disease activity in RA, providing a promising avenue for patient stratification and diagnostics.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-32428-4","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T01:50:55Z","timestamp":1680486655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity"],"prefix":"10.1038","volume":"13","author":[{"given":"Kevin Y.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"Arment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delamo I.","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara E.","family":"Delger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Crowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Myasoedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Weyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"32428_CR1","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid, J. et al. Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: Anti-CP status predicts worse disease activity and greater radiological progression. Ann. Rheum. Dis. 64, 1744\u20131749 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/annrheumdis-2017-211325","volume":"76","author":"LE Burgers","year":"2017","unstructured":"Burgers, L. E., van Steenbergen, H. W., Ten Brinck, R. M., Huizinga, T. W. & van der Helm-van Mil, A. H. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: A longitudinal study in arthralgia during progression to clinical arthritis. Ann. Rheum. Dis. 76, 1751\u20131754 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00296-019-04492-5","volume":"40","author":"J Grosse","year":"2020","unstructured":"Grosse, J. et al. ACPA-positive versus ACPA-negative rheumatoid arthritis: Two distinct erosive disease entities on radiography and ultrasonography. Rheumatol. Int. 40, 615\u2013624 (2020).","journal-title":"Rheumatol. Int."},{"key":"32428_CR4","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar4439","volume":"16","author":"SD Seegobin","year":"2014","unstructured":"Seegobin, S. D. et al. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: Secondary analysis of a randomized controlled trial. Arthritis Res. Ther. 16, R13 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"32428_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrrheum.2011.28","volume":"7","author":"NA Daha","year":"2011","unstructured":"Daha, N. A. & Toes, R. E. M. Rheumatoid arthritis: Are ACPA-positive and ACPA-negative RA the same disease?. Nat. Rev. Rheumatol. 7, 202\u2013203 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"32428_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/ard.2009.126821","volume":"70","author":"L Padyukov","year":"2011","unstructured":"Padyukov, L. et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann. Rheum. Dis. 70, 259\u2013265 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","volume":"79","author":"E Myasoedova","year":"2020","unstructured":"Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014. Ann. Rheum. Dis. 79, 440\u2013444 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12967-021-03169-7","volume":"19","author":"H Luan","year":"2021","unstructured":"Luan, H. et al. Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients. J. Transl. Med. 19, 500 (2021).","journal-title":"J. Transl. Med."},{"key":"32428_CR9","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1038\/s41467-021-25246-7","volume":"12","author":"X Wu","year":"2021","unstructured":"Wu, X. et al. Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis. Nat. Commun. 12, 4977 (2021).","journal-title":"Nat. Commun."},{"key":"32428_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cells10030647","volume":"10","author":"A Floudas","year":"2021","unstructured":"Floudas, A. et al. ACPA status correlates with differential immune profile in patients with rheumatoid arthritis. Cells 10, 647 (2021).","journal-title":"Cells"},{"key":"32428_CR11","doi-asserted-by":"publisher","first-page":"eabm1511","DOI":"10.1126\/sciadv.abm1511","volume":"8","author":"J He","year":"2022","unstructured":"He, J. et al. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci. Adv. 8, eabm1511 (2022).","journal-title":"Sci. Adv."},{"key":"32428_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biomedicines8060141","volume":"8","author":"TBG Poulsen","year":"2020","unstructured":"Poulsen, T. B. G. et al. Identification of novel native autoantigens in rheumatoid arthritis. Biomedicines 8, 141 (2020).","journal-title":"Biomedicines"},{"key":"32428_CR13","doi-asserted-by":"publisher","first-page":"17300","DOI":"10.1038\/s41598-021-96675-z","volume":"11","author":"TBG Poulsen","year":"2021","unstructured":"Poulsen, T. B. G. et al. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays. Sci. Rep. 11, 17300 (2021).","journal-title":"Sci. Rep."},{"key":"32428_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","volume":"22","author":"E Reed","year":"2020","unstructured":"Reed, E. et al. Presence of autoantibodies in \u201cseronegative\u201d rheumatoid arthritis associates with classical risk factors and high disease activity. Arthritis Res. Ther. 22, 170 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"32428_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/annrheumdis-2020-218460","volume":"80","author":"K Li","year":"2021","unstructured":"Li, K. et al. Novel autoantibodies identified in ACPA-negative rheumatoid arthritis. Ann. Rheum. Dis. 80, 739\u2013747 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10\u201318 (2021).","journal-title":"Nat. Immunol."},{"key":"32428_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.009","volume":"91","author":"MJ Lewis","year":"2018","unstructured":"Lewis, M. J. et al. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus. J. Autoimmun. 91, 1\u201312 (2018).","journal-title":"J. Autoimmun."},{"key":"32428_CR18","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1177\/0961203320959696","volume":"29","author":"A Mak","year":"2020","unstructured":"Mak, A. et al. Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform. Lupus 29, 1948\u20131954 (2020).","journal-title":"Lupus"},{"key":"32428_CR19","doi-asserted-by":"publisher","first-page":"30539","DOI":"10.18632\/oncotarget.25669","volume":"9","author":"P Zaenker","year":"2018","unstructured":"Zaenker, P. et al. A diagnostic autoantibody signature for primary cutaneous melanoma. Oncotarget 9, 30539\u201330551 (2018).","journal-title":"Oncotarget"},{"key":"32428_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41416-021-01572-x","volume":"126","author":"AJ Patel","year":"2022","unstructured":"Patel, A. J. et al. A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications. Br. J. Cancer 126, 238\u2013246 (2022).","journal-title":"Br. J. Cancer"},{"key":"32428_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/v13050786","volume":"13","author":"M Smith","year":"2021","unstructured":"Smith, M. et al. Age, disease severity and ethnicity influence humoral responses in a multi-ethnic COVID-19 cohort. Viruses 13, 786 (2021).","journal-title":"Viruses"},{"key":"32428_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13059-018-1560-8","volume":"19","author":"EE Davenport","year":"2018","unstructured":"Davenport, E. E. et al. Discovering in vivo cytokine-eQTL interactions from a lupus clinical trial. Genome Biol. 19, 168 (2018).","journal-title":"Genome Biol."},{"key":"32428_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2007.10.004","volume":"41","author":"TW Kragstrup","year":"2008","unstructured":"Kragstrup, T. W. et al. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41, 16\u201323 (2008).","journal-title":"Cytokine"},{"key":"32428_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","volume":"95","author":"M Rojas","year":"2018","unstructured":"Rojas, M. et al. Molecular mimicry and autoimmunity. J. Autoimmun. 95, 100\u2013123 (2018).","journal-title":"J. Autoimmun."},{"issue":"6","key":"32428_CR25","doi-asserted-by":"publisher","first-page":"BSR20200466","DOI":"10.1042\/BSR20200466","volume":"40","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. miR-137 targets the inhibition of TCF4 to reverse the progression of osteoarthritis through the AMPK\/NF-\u03baB signaling pathway. Biosci. Rep. 40(6), BSR20200466. https:\/\/doi.org\/10.1042\/BSR20200466 (2020).","journal-title":"Biosci. Rep."},{"key":"32428_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nri2214","volume":"7","author":"KS Ravichandran","year":"2007","unstructured":"Ravichandran, K. S. & Lorenz, U. Engulfment of apoptotic cells: signals for a good meal. Nat. Rev. Immunol. 7, 964\u2013974 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"32428_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaut.2008.04.009","volume":"31","author":"A Lleo","year":"2008","unstructured":"Lleo, A., Selmi, C., Invernizzi, P., Podda, M. & Gershwin, M. E. The consequences of apoptosis in autoimmunity. J. Autoimmun. 31, 257\u2013262 (2008).","journal-title":"J. Autoimmun."},{"key":"32428_CR28","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","volume":"168","author":"M Kalaaji","year":"2006","unstructured":"Kalaaji, M., Mortensen, E., J\u00f8rgensen, L., Olsen, R. & Rekvig, O. P. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am. J. Pathol. 168, 1779\u20131792 (2006).","journal-title":"Am. J. Pathol."},{"key":"32428_CR29","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","volume":"9","author":"O Cabral-Marques","year":"2018","unstructured":"Cabral-Marques, O. et al. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat. Commun. 9, 5224 (2018).","journal-title":"Nat. Commun."},{"key":"32428_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-3-642-79850-4_6","volume":"16","author":"S Nagata","year":"1996","unstructured":"Nagata, S. Apoptosis mediated by the Fas system. Prog. Mol. Subcell. Biol. 16, 87\u2013103 (1996).","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"32428_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH746>3.0.CO;2-K","volume":"193","author":"CT Chou","year":"2001","unstructured":"Chou, C. T., Yang, J. S. & Lee, M. R. Apoptosis in rheumatoid arthritis\u2013expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J. Pathol. 193, 110\u2013116 (2001).","journal-title":"J. Pathol."},{"key":"32428_CR32","first-page":"1925","volume":"20","author":"L Peng","year":"2020","unstructured":"Peng, L. et al. Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity. Exp. Ther. Med. 20, 1925\u20131934 (2020).","journal-title":"Exp. Ther. Med."},{"key":"32428_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/rheumatology\/kex462","volume":"57","author":"S Vordenb\u00e4umen","year":"2018","unstructured":"Vordenb\u00e4umen, S. et al. High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford) 57, 533\u2013537 (2018).","journal-title":"Rheumatology (Oxford)"},{"key":"32428_CR34","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41467-022-28905-5","volume":"13","author":"O Cabral-Marques","year":"2022","unstructured":"Cabral-Marques, O. et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat. Commun. 13, 1220 (2022).","journal-title":"Nat. Commun."},{"key":"32428_CR35","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1158\/1078-0432.CCR-09-3192","volume":"16","author":"EC Farlow","year":"2010","unstructured":"Farlow, E. C. et al. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin. Cancer Res. 16, 3452\u20133462 (2010).","journal-title":"Clin. Cancer Res."},{"key":"32428_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1074\/mcp.M100029-MCP200","volume":"1","author":"F Le Naour","year":"2002","unstructured":"Le Naour, F. et al. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol. Cell. Proteomics 1, 197\u2013203 (2002).","journal-title":"Mol. Cell. Proteomics"},{"key":"32428_CR37","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1073\/pnas.0914213107","volume":"107","author":"S Gnjatic","year":"2010","unstructured":"Gnjatic, S. et al. Seromic profiling of ovarian and pancreatic cancer. Proc. Natl. Acad. Sci. U. S. A. 107, 5088\u20135093 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"32428_CR38","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W Katchamart","year":"2015","unstructured":"Katchamart, W., Koolvisoot, A., Aromdee, E., Chiowchanwesawakit, P. & Muengchan, C. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol. Int. 35, 1693\u20131699 (2015).","journal-title":"Rheumatol. Int."},{"issue":"Suppl 1","key":"32428_CR39","doi-asserted-by":"publisher","first-page":"i51","DOI":"10.1136\/ard.2010.138040","volume":"70","author":"RRP de Vries","year":"2011","unstructured":"de Vries, R. R. P., van der Woude, D., Houwing, J. J. & Toes, R. E. M. Genetics of ACPA-positive rheumatoid arthritis: The beginning of the end?. Ann. Rheum. Dis. 70(Suppl 1), i51\u2013i54 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"32428_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13075-015-0623-4","volume":"17","author":"C Terao","year":"2015","unstructured":"Terao, C. et al. Anti-citrullinated peptide\/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: A meta-analysis of genome-wide association study in a Japanese population. Arthritis Res. Ther. 17, 104 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"32428_CR41","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"32428_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2006.02.003","volume":"174","author":"FJ Quintana","year":"2006","unstructured":"Quintana, F. J. & Weiner, H. L. Understanding natural and pathological autoimmunity. J. Neuroimmunol. 174, 1\u20132 (2006).","journal-title":"J. Neuroimmunol."},{"key":"32428_CR43","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1002\/art.21252","volume":"52","author":"Y Shoenfeld","year":"2005","unstructured":"Shoenfeld, Y. & Toubi, E. Protective autoantibodies: Role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum. 52, 2599\u20132606 (2005).","journal-title":"Arthritis Rheum."},{"key":"32428_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.it.2008.10.002","volume":"30","author":"HU Lutz","year":"2009","unstructured":"Lutz, H. U., Binder, C. J. & Kaveri, S. Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol. 30, 43\u201351 (2009).","journal-title":"Trends Immunol."},{"key":"32428_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jaut.2011.05.007","volume":"37","author":"B Wootla","year":"2011","unstructured":"Wootla, B. et al. Autoantibodies with enzymatic properties in human autoimmune diseases. J. Autoimmun. 37, 144\u2013150 (2011).","journal-title":"J. Autoimmun."},{"issue":"Suppl 1","key":"32428_CR46","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/s10875-014-0025-4","volume":"34","author":"C Gr\u00f6nwall","year":"2014","unstructured":"Gr\u00f6nwall, C. & Silverman, G. J. Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease. J. Clin. Immunol. 34(Suppl 1), S12-21 (2014).","journal-title":"J. Clin. Immunol."},{"key":"32428_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrrheum.2013.30","volume":"9","author":"GJ Silverman","year":"2013","unstructured":"Silverman, G. J., Vas, J. & Gr\u00f6nwall, C. Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat. Rev. Rheumatol. 9, 291\u2013300 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"32428_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916934.2019.1581774","volume":"52","author":"M Neiman","year":"2019","unstructured":"Neiman, M. et al. Individual and stable autoantibody repertoires in healthy individuals. Autoimmunity 52, 1\u201311 (2019).","journal-title":"Autoimmunity"},{"key":"32428_CR49","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.celrep.2022.110873","volume":"39","author":"M Shome","year":"2022","unstructured":"Shome, M. et al. Serum autoantibodyome reveals that healthy individuals share common autoantibodies. Cell Rep. 39, 110873 (2022).","journal-title":"Cell Rep."},{"key":"32428_CR50","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3390\/jcm10153289","volume":"10","author":"Y Xu","year":"2021","unstructured":"Xu, Y. & Wu, Q. Prevalence trend and disparities in rheumatoid arthritis among US adults, 2005\u20132018. J. Clin. Med. 10, 3289 (2021).","journal-title":"J. Clin. Med."},{"key":"32428_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nrrheum.2018.23","volume":"14","author":"G Barturen","year":"2018","unstructured":"Barturen, G., Beretta, L., Cervera, R., Van Vollenhoven, R. & Alarc\u00f3n-Riquelme, M. E. Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 14, 180 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"32428_CR52","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/biot.201100305","volume":"7","author":"J Sung","year":"2012","unstructured":"Sung, J., Wang, Y., Chandrasekaran, S., Witten, D. M. & Price, N. D. Molecular signatures from omics data: from chaos to consensus. Biotechnol. J. 7, 946\u2013957 (2012).","journal-title":"Biotechnol. J."},{"key":"32428_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13073-021-00957-0","volume":"13","author":"VK Gupta","year":"2021","unstructured":"Gupta, V. K. et al. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med. 13, 149 (2021).","journal-title":"Genome Med."},{"key":"32428_CR54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-021-02537-4","volume":"23","author":"B Hur","year":"2021","unstructured":"Hur, B. et al. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity. Arthritis Res. Ther. 23, 164 (2021).","journal-title":"Arthritis Res. Ther."},{"key":"32428_CR55","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1038\/s41467-020-18476-8","volume":"11","author":"VK Gupta","year":"2020","unstructured":"Gupta, V. K. et al. A predictive index for health status using species-level gut microbiome profiling. Nat. Commun. 11, 4635 (2020).","journal-title":"Nat. Commun."},{"key":"32428_CR56","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.mayocp.2019.05.023","volume":"94","author":"CM Coffey","year":"2019","unstructured":"Coffey, C. M., Crowson, C. S., Myasoedova, E., Matteson, E. L. & Davis, J. M. 3rd. Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: Missing the window of opportunity. Mayo Clin. Proc. 94, 2241\u20132248 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"32428_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","volume":"45","author":"EA Littlejohn","year":"2018","unstructured":"Littlejohn, E. A. & Monrad, S. U. Early diagnosis and treatment of rheumatoid arthritis. Prim. Care 45, 237\u2013255 (2018).","journal-title":"Prim. Care"},{"key":"32428_CR58","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"32428_CR59","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 335, 806\u2013808 (2007).","journal-title":"BMJ"},{"key":"32428_CR60","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha, D. & Smolen, J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin. Exp. Rheumatol. 23, S100\u2013S108 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"key":"32428_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-61779-349-3_10","volume":"800","author":"JM Blackburn","year":"2012","unstructured":"Blackburn, J. M., Shoko, A. & Beeton-Kempen, N. Miniaturised, microarray-based assays for chemical proteomic studies of protein function. Chem. Genomics Proteomics Methods Mol. Biol. 800, 133\u2013162 (2012).","journal-title":"Chem. Genomics Proteomics Methods Mol. Biol."},{"key":"32428_CR62","volume-title":"Ordinal Methods for Behavioral Data Analysis","author":"N Cliff","year":"2016","unstructured":"Cliff, N. Ordinal Methods for Behavioral Data Analysis (Psychology Press, 2016)."},{"key":"32428_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32428-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T02:03:53Z","timestamp":1680487433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32428-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32428-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Davis has a research grant from Pfizer and has rights to royalties for technology licensed to Girihlet. Neither Pfizer nor Girihlet had any role in the design or conduct of this study. All other authors do not possess any conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5360"}}